These gains stem from the sector’s ability to maintain growth momentum, supported by new product launches, stable generics ...

The U.S. is one of only two countries that legally allows drugmakers to advertise products directly to patients. There are ...

The biotech stock's price-to-earnings-to-growth (PEG) ratio is a super-low 0.58, according to the London Stock Exchange Group (LSEG). Any PEG ratio below 1.0 is viewed as an attractive valuation.

Nvidia has been the hottest stock since the start of the AI revolution, and I see one particular healthcare business ...

Elisabeth Rosenthal Triumphant music plays as cancer patients go camping, do some gardening, and watch fireworks in ads for Opdivo+Yervoy, a combination of immunotherapies to treat […] ...

In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of ...

According to an IMS report (2011) the contribution of emerging markets to the growth of the pharmaceutical market has increased from 8% in 2003 to 40% in 2010. For example, in 2008 Chinese ...

The Drugs Controller General of India (DCGI) has declared as many as 16 commonly-used medicines as spurious, after they ...

Mutual Fund has introduced a new Manufacturing Fund, an open-ended equity scheme, aiming to capitalize on the growth ...

Whilst most of those working in the pharmaceutical industry have felt the pressures of rising costs and thinning pipelines over the last twenty years, some entrepreneurial souls have managed to ...

Going ahead, the positive move is likely to sustain in the benchmark indices despite underperfromance of broader markets. The ...

Rocket Lab made its publicly traded debut in 2021 and surged as high as $21 per share. However, the stock remains 67% below ...